Many scholars have found that lung cancer develops due to activating mutations of many driver genes, such as epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), c-ROS oncogene 1 receptor tyrosine kinase (ROS1), and Kirsten rat sarcoma viral oncogene [8, 9]. This evidence concerns the gene EGFR and lung cancer.